Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite.
The intercalation of perindopril erbumine into Zn/Al-NO3-layered double hydroxide resulted in the formation of a host-guest type of material. By virtue of the ionexchange properties of layered double hydroxide, perindopril erbumine was released in a sustained manner. Therefore, this intercalated mat...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English English |
Published: |
Dove Medical Press
2012
|
Online Access: | http://psasir.upm.edu.my/id/eprint/24618/1/Controlled%20release%20and%20angiotensin.pdf http://psasir.upm.edu.my/id/eprint/24618/ http://www.dovepress.com/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
my.upm.eprints.24618 |
---|---|
record_format |
eprints |
spelling |
my.upm.eprints.246182015-09-14T00:05:49Z http://psasir.upm.edu.my/id/eprint/24618/ Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite. Hussein Al Ali, Samer Hasan Al-Qubaisi, Mothanna Hussein, Mohd Zobir Ismail, Maznah Zainal, Zulkarnain Abdullah, Muhammad Nazrul Hakim The intercalation of perindopril erbumine into Zn/Al-NO3-layered double hydroxide resulted in the formation of a host-guest type of material. By virtue of the ionexchange properties of layered double hydroxide, perindopril erbumine was released in a sustained manner. Therefore, this intercalated material can be used as a controlled-release formulation. Results: Perindopril was intercalated into the interlayers and formed a well ordered, layered organic-inorganic nanocomposite. The basal spacing of the products was expanded to 21.7 Å and 19.9 Å by the ion-exchange and coprecipitation methods, respectively, in a bilayer and a monolayer arrangement, respectively. The release of perindopril from the nanocomposite synthesized by the coprecipitation method was slower than that of its counterpart synthesized by the ion-exchange method. The rate of release was governed by pseudo-second order kinetics. An in vitro antihypertensive assay showed that the intercalation process results in effectiveness similar to that of the antihypertensive properties of perindopril. Conclusion: Intercalated perindopril showed better thermal stability than its free counterpart. The resulting material showed sustained-release properties and can therefore be used as a controlled-release formulation. Dove Medical Press 2012 Article PeerReviewed application/pdf en http://psasir.upm.edu.my/id/eprint/24618/1/Controlled%20release%20and%20angiotensin.pdf Hussein Al Ali, Samer Hasan and Al-Qubaisi, Mothanna and Hussein, Mohd Zobir and Ismail, Maznah and Zainal, Zulkarnain and Abdullah, Muhammad Nazrul Hakim (2012) Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite. International Journal of Nanomedicine, 7 (1). pp. 2129-2141. ISSN 1176-9114; ESSN:1178-2013 http://www.dovepress.com/ 10.2147/IJN.S30461 English |
institution |
Universiti Putra Malaysia |
building |
UPM Library |
collection |
Institutional Repository |
continent |
Asia |
country |
Malaysia |
content_provider |
Universiti Putra Malaysia |
content_source |
UPM Institutional Repository |
url_provider |
http://psasir.upm.edu.my/ |
language |
English English |
description |
The intercalation of perindopril erbumine into Zn/Al-NO3-layered double hydroxide resulted in the formation of a host-guest type of material. By virtue of the ionexchange properties of layered double hydroxide, perindopril erbumine was released in a sustained manner. Therefore, this intercalated material can be used as a controlled-release formulation. Results: Perindopril was intercalated into the interlayers and formed a well ordered, layered organic-inorganic nanocomposite. The basal spacing of the products was expanded to 21.7 Å and 19.9 Å by the ion-exchange and coprecipitation methods, respectively, in a bilayer and a monolayer arrangement, respectively. The release of perindopril from the nanocomposite synthesized by the coprecipitation method was slower than that of its counterpart synthesized by the ion-exchange method. The rate of release was governed by pseudo-second order kinetics. An in vitro antihypertensive assay showed that the intercalation process results in effectiveness similar to that of the antihypertensive properties of perindopril. Conclusion: Intercalated perindopril showed better thermal stability than its free counterpart. The resulting material showed sustained-release properties and can therefore be used as a controlled-release formulation. |
format |
Article |
author |
Hussein Al Ali, Samer Hasan Al-Qubaisi, Mothanna Hussein, Mohd Zobir Ismail, Maznah Zainal, Zulkarnain Abdullah, Muhammad Nazrul Hakim |
spellingShingle |
Hussein Al Ali, Samer Hasan Al-Qubaisi, Mothanna Hussein, Mohd Zobir Ismail, Maznah Zainal, Zulkarnain Abdullah, Muhammad Nazrul Hakim Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite. |
author_facet |
Hussein Al Ali, Samer Hasan Al-Qubaisi, Mothanna Hussein, Mohd Zobir Ismail, Maznah Zainal, Zulkarnain Abdullah, Muhammad Nazrul Hakim |
author_sort |
Hussein Al Ali, Samer Hasan |
title |
Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite. |
title_short |
Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite. |
title_full |
Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite. |
title_fullStr |
Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite. |
title_full_unstemmed |
Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite. |
title_sort |
controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite. |
publisher |
Dove Medical Press |
publishDate |
2012 |
url |
http://psasir.upm.edu.my/id/eprint/24618/1/Controlled%20release%20and%20angiotensin.pdf http://psasir.upm.edu.my/id/eprint/24618/ http://www.dovepress.com/ |
_version_ |
1643828415827017728 |
score |
13.18916 |